Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD)
Fishman commentary: Treatment pearls for dupilumab associated ocular surface disease. Authors: JodieRaffiabRaaginiSureshaTimothyBergeraHarveyFishmancJenny E.Murasead https://doi.org/10.1016/j.ijwd.2019.08.007 International Journal of Women’s Dermatology . Available online […]